The Fast Track Push Is Coming
“Fast track” trade promotion authority, if passed, means Congress yields its constitutional authority and obligation to review and amend trade agreements. A “fast track” treaty has to be voted on quickly, cannot be amended, and Congress has to give it an up-or-down vote.
The U.S. Trade Representative (USTR) Michael Froman is pushing Congress to pass “fast track,” in hope of pushing through the TPP agreement by the end of the year. Politico lays it out, in “Froman pushing Congress to finalize trade deals,”
President Barack Obama was often criticized in his first term for moving too slowly on trade, but now his chief negotiator is pressing Congress to pick up the pace as the White House pushes to conclude a landmark trade deal in the Asia-Pacific by the end of the year.
[. . .] Froman and his team at USTR are pushing to finish the TPP talks by the end of the year, putting pressure on Congress to move a TPA bill to set the stage for the final phase of talks.
Fast Track To Push TPP
The next “trade” treaty will be the Trans-Pacific Partnership (TPP). This is a huge treaty with only a small part covering trade. Most of the agreement (according to leaks) sets down a new kind of regulatory structure for the giant corporations that would supersede the ability of any country to rein them in. The treaty is being negotiated in secret with only business interests “at the table.” Representatives of others with a stake in the outcome are not part of the process. Groups representing the interests of consumers, labor, human rights, the environment, democracy or even smaller and innovative companies that might want to compete with the giant multinationals are not part of the negotiations.
Economist Dean Baker explains that TPP is not about “free trade” and growth, writing,
Of course the TPP is not about free trade, in most cases the formal trade barriers between the countries negotiating the pact are relatively low. The main thrust of the negotiations is to impose a regulator structure in a wide range of areas — health, safety, environmental — which will override national and sub-national rules. This has little to do with trade and in some cases, such as the increased patent protection for prescription drugs being pushed as part of the deal (which is noted in the article), will actually involve increased barriers to trade.
In The Trans-Pacific Partnership: A Trade Agreement for Protectionists, Baker writes, “The
TPP is about crafting rules that will favor big business at the expense of the rest of the population in both the United States and in other countries.
… The world has benefited from the opening of trade over the last four decades. But this opening has been selective so that, at least in the United States, most of the gains have gone to those at the top. It is possible to design trade deals that benefit the population as a whole, but not when corporate interests are literally the negotiators at the table.